1. Biocryst Pharmaceuticals Inc.
  2. Biocryst Pharmaceuticals Inc. Ownership

Historical shareholding details of Vanguard Russell 2000 Index Fund holdings in Biocryst Pharmaceuticals Inc. (BCRX)

Monthly changes of Vanguard Russell 2000 Index Fund shareholding in Biocryst Pharmaceuticals Inc. over the previous months

Month Name Total no. shares held Percent Holding
Jul 31, 2025 Vanguard Russell 2000 Index Fund 998,275 0.48%
Jun 30, 2025 Vanguard Russell 2000 Index Fund 1,066,669 0.51%
May 31, 2025 Vanguard Russell 2000 Index Fund 1,045,090 0.50%
Apr 30, 2025 Vanguard Russell 2000 Index Fund 1,029,967 0.49%
Mar 31, 2025 Vanguard Russell 2000 Index Fund 969,227 0.46%
Feb 28, 2025 Vanguard Russell 2000 Index Fund 944,623 0.45%
Jan 31, 2025 Vanguard Russell 2000 Index Fund 919,130 0.44%
Dec 31, 2024 Vanguard Russell 2000 Index Fund 979,674 0.47%
Nov 30, 2024 Vanguard Russell 2000 Index Fund 972,663 0.47%
Oct 31, 2024 Vanguard Russell 2000 Index Fund 941,866 0.45%
Sep 30, 2024 Vanguard Russell 2000 Index Fund 947,738 0.46%
Aug 31, 2024 Vanguard Russell 2000 Index Fund 839,161 0.41%
Jul 31, 2024 Vanguard Russell 2000 Index Fund 814,642 0.39%
Jun 30, 2024 Vanguard Russell 2000 Index Fund 769,275 0.37%
May 31, 2024 Vanguard Russell 2000 Index Fund 708,290 0.34%
Apr 30, 2024 Vanguard Russell 2000 Index Fund 713,762 0.35%
Mar 31, 2024 Vanguard Russell 2000 Index Fund 705,478 0.34%
Feb 29, 2024 Vanguard Russell 2000 Index Fund 689,428 0.33%
Jan 31, 2024 Vanguard Russell 2000 Index Fund 635,415 0.31%
Dec 31, 2023 Vanguard Russell 2000 Index Fund 621,510 0.30%
Nov 30, 2023 Vanguard Russell 2000 Index Fund 585,067 0.29%
Oct 31, 2023 Vanguard Russell 2000 Index Fund 573,857 0.28%
Sep 30, 2023 Vanguard Russell 2000 Index Fund 550,833 0.29%
Aug 31, 2023 Vanguard Russell 2000 Index Fund 545,829 0.29%
Jul 31, 2023 Vanguard Russell 2000 Index Fund 534,142 0.28%
Jun 30, 2023 Vanguard Russell 2000 Index Fund 522,613 0.28%
May 31, 2023 Vanguard Russell 2000 Index Fund 501,816 0.27%
Apr 30, 2023 Vanguard Russell 2000 Index Fund 500,334 0.26%

View all ownership details of Biocryst Pharmaceuticals Inc.